Sanofi Expands Immunology Footprint with $9.1 Billion Blueprint Medicines Acquisition
Sanofi has announced an agreement to acquire Blueprint Medicines Corporation, a US-based…
Sanofi to acquire Vigil Neuroscience, Inc., adding a newinvestigational medicine to treat Alzheimer’s disease to theneurology pipeline
Sanofi announced today that it has entered into an agreement to acquire…
Sanofi Exceeds Forecasts with Strong Sales of Skin and Asthma Treatments
Sanofi kicked off the year with a strong performance, posting better-than-expected sales…
Sanofi and CD&R sign Opella share Purchase Agreement
Paris- February 19 2025- Following completion of the required social and corporate…
Sanofi begins Phase 3 trials for PCV21, expands SK Bioscience partnership
Paris- 23 December 2024- Sanofi and SK bioscience have entered into a…
Audrey Duval Derveloy appointed Global Head of Corporate Affairs at Sanofi
Paris- June 2024- Sanofi has named Audrey Duval Derveloy, a seasoned healthcare…
Sanofi, Formation Bio and OpenAI announce first-in-class AI collaboration
Paris, New York- May, 2024- Sanofi, Formation Bio and OpenAI are collaborating…
Sanofi and Novavax announce co-exclusive licensing agreement
Paris and Gaithersburg- May, 2024- As part of Sanofi’s commitment to developing…
Egyptian Drug Authority participates in the African Drug Summit
Cairo hosted the African Summit for Drug Regulatory Affairs, with the Egyptian…